Medifast, Inc. MED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 76.38M | 76.04M | 75.10M | 89.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 76.38M | 76.04M | 75.10M | 89.41M |
| Cost of Revenue | -- | 22.99M | 24.29M | 22.96M | -- |
| Gross Profit | -- | 53.40M | 51.76M | 52.14M | -- |
| SG&A Expenses | -- | 57.72M | 56.14M | 58.94M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 80.71M | 81.52M | 82.90M | 93.49M |
| Operating Income | -- | -4.33M | -5.48M | -7.80M | -4.08M |
| Income Before Tax | -- | -2.99M | -1.94M | -6.38M | -- |
| Income Tax Expenses | -- | 109.00K | 181.00K | 11.74M | -- |
| Earnings from Continuing Operations | -- | -3.10M | -2.12M | -18.12M | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -3.10M | -2.12M | -18.12M | -2.26M |
| EBIT | -- | -4.33M | -5.48M | -7.80M | -4.08M |
| EBITDA | -- | -881.00K | -2.00M | -4.34M | -629.00K |
| EPS Basic | -1.57 | -0.28 | -0.19 | -1.65 | -0.21 |
| Normalized Basic EPS | -1.00 | -0.17 | -0.23 | -0.36 | -0.15 |
| EPS Diluted | -1.57 | -0.28 | -0.19 | -1.65 | -0.21 |
| Normalized Diluted EPS | -1.00 | -0.17 | -0.23 | -0.36 | -0.15 |
| Average Basic Shares Outstanding | 11.18M | 11.14M | 11.01M | 10.99M | 10.99M |
| Average Diluted Shares Outstanding | 11.18M | 11.14M | 11.01M | 10.99M | 10.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -2.68% | -4.10% | 0.00% | 0.00% |